Search LYB
LyondellBasell Industries N.V.
NYSE · CIK 1489393
Last close58.58
Daily change+0.80 (1.38%)
10 Years gain+32.86%
Dividends TTM3.44 (-36.53%)
Dividend yield5.95%
Fundamental Analysis
LYB · STANDARD
SIC 2860 · Industrial Organic Chemicals · Fiscal year end 1231
Fundamental
37.3Momentum
31.5Acceleration
31.5Confidence
81.0Annual Revenue15
Quarterly Revenue70
Annual CFO15
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth0.0 / 25
Quality12.5 / 25
Capital Efficiency8.0 / 20
Balance Sheet15.0 / 15
Shareholder Economics0.0 / 10
Forward Indicators0.0 / 5
Signals
Gross margin expansionGross margin improved by 0.7633 percentage points.
Net debt reductionNet debt declined versus the comparison period.
Warnings
Operating margin compression · MEDIUMOperating margin compressed by 3.697 percentage points.
Key Metrics
Revenue Growth TTM-4.52%OK
Revenue CAGR 3Y-15.77%OK
Gross Margin13.96%OK
Operating Margin4.21%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC10.76%OK
Incremental Operating Margin 3Yn/aNOT_MEANINGFUL
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Yn/aINSUFFICIENT_HISTORY
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $30.15B | $2.58B | -$420.00M | $2.26B | $384.00M | 8.55% | -1.39% | 1.27% | -5.81% | n/a |
| 2025 FY Dec 31, 2024 | $33.39B | $4.64B | $1.92B | $3.82B | $1.98B | 13.91% | 5.74% | 5.93% | 23.53% | n/a |
| 2025 FY Dec 31, 2023 | $33.34B | $4.90B | $2.73B | $4.94B | $3.41B | 14.7% | 8.17% | 10.23% | 24.52% | n/a |
| 2024 FY Dec 31, 2022 | $50.45B | $6.60B | $5.10B | $6.12B | $4.23B | 13.09% | 10.11% | 8.38% | 38.59% | n/a |
| 2023 FY Dec 31, 2021 | $46.17B | $8.78B | $6.77B | $7.70B | $5.74B | 19.01% | 14.67% | 12.42% | 66.39% | n/a |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $31.76B | sum latest 4 fiscal quarters Revenue | OK | 0001489393-26-000061, 0001489393-25-000056 |
| Revenue Growth TTM | -4.52% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001489393-26-000061, 0001489393-25-000056 |
| Revenue CAGR 3Y | -15.77% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001489393-26-000012 |
| Revenue CAGR 5Y | 2.24% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001489393-26-000012 |
| Gross Profit CAGR 3Y | -26.93% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001489393-26-000012 |
| Operating Income Growth | -49.18% | OperatingIncome_current / OperatingIncome_prior_year - 1 | OK | 0001489393-26-000061, 0001489393-25-000056 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 13.96% | Gross Profit / Revenue | OK | 0001489393-26-000061, 0001489393-25-000056 |
| Operating Margin | 4.21% | Operating Income / Revenue | OK | 0001489393-26-000061, 0001489393-25-000056 |
| ROIC | 10.76% | NOPAT / Average Invested Capital | OK | 0001489393-26-000061, 0001489393-25-000056 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001489393-26-000061 |
| Current Ratio | 1.64x | Current Assets / Current Liabilities | OK | derived |
| Cash / Debt | 17.37x | (Cash + Short-term Investments) / Total Debt | OK | 0001489393-26-000061 |
| SBC / FCF | n/a | SBC / FCF | NOT_MEANINGFUL | derived |